WASHINGTON, Oct. 5, 2023
/PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA)
today announced that the company will participate in the Jefferies
Inaugural Biotech CNS/Neuro Summit in New
York City on Wednesday, October 11,
2023. A corporate presentation is scheduled for 1:30 p.m. Eastern Time.
The corporate presentation given at the Jefferies Inaugural
Biotech CNS/Neuro Summit may be accessed live on Vanda's corporate
website, www.vandapharma.com. Investors should click on the
Investors tab and follow the link under Recent Events. Investors
are advised to go to the conference website at least 15 minutes
early to register, download, and install any necessary software or
presentations. A link to the archived conference will be available
on Vanda's website for a period of approximately 30 days.
About Vanda Pharmaceuticals Inc.
Vanda is a leading global biopharmaceutical company focused on
the development and commercialization of innovative therapies to
address high unmet medical needs and improve the lives of patients.
For more on Vanda Pharmaceuticals Inc., please visit
www.vandapharma.com and follow us on X @vandapharma.
Corporate Contact:
Kevin
Moran
Senior Vice President, Chief Financial Officer and Treasurer
Vanda Pharmaceuticals Inc.
202-734-3400
pr@vandapharma.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/vanda-pharmaceuticals-announces-participation-in-the-jefferies-inaugural-biotech-cnsneuro-summit-301949013.html
SOURCE Vanda Pharmaceuticals Inc.